Clinical Governance Committees: From process overload to outcome-driven assurance
20 April 2026
Andrew Corbett-Nolan argues that NHS clinical governance committees must shift from process-heavy reporting to outcome-focused assurance
Clinical governance has been a cornerstone of NHS accountability for over 25 years. First formalised in the wake of the Bristol heart scandal and reinforced by subsequent inquiries, from Shipman to Francis and Ockenden, it is defined as “a framework through which NHS organisations are accountable for continually improving the quality of their services and safeguarding high standards of care by creating an environment in which excellence in clinical care will flourish.” At its heart lies a commitment to patient safety, clinical effectiveness and positive patient experience. Yet for many boards and their quality committees, delivering on this promise remains frustratingly elusive.
The quality or clinical governance committee, chaired by a non-executive director and supported by the Chief Nurse as executive lead, alongside the Medical Director and other key executives, sits at the apex of the board’s assurance system. Guided by the Board Assurance Framework (BAF), its role is to triangulate evidence from the patient safety, clinical effectiveness and patient experience domains and provide the board with credible assurance. Many clinical governance committees also have a responsibility to drive improvement within their terms of reference. Management groups at divisional and thematic levels (safety, effectiveness, experience, infection prevention, etc.) provide reports and reporting to the committee. In theory, this structure should create a clear line of sight from ward to board. In practice, too many committees are drowning in process-heavy papers while starved of the hard metrics that would let them answer the questions that really matter: Is our hospital safer this year than last? Are clinical outcomes improving? Is patient satisfaction rising? And, crucially, are we on a trajectory to be safer and better still next year?
GGi’s governance reviews repeatedly highlight the same pattern. Committee packs routinely exceed perhaps 20 papers many running to dozens of pages – so a committee pack the size of a novella will often be the reading committee members are supposedly needing to digest. Agendas stretch into marathon sessions that overrun, forcing last-minute rationalisation. Papers describe policies reviewed, incidents logged, audits completed, training delivered and compliance checklists ticked. They are thorough on process but thin – indeed often silent – on outcomes. A patient-experience paper may summarise Friends and Family Test response rates yet offer no trend analysis against national benchmarks or correlation with serious incident themes. Risk registers list scores but rarely demonstrate whether the organisation is materially reducing harm.
The consequence is predictable. Committees cannot easily discern signal from noise. Assurance becomes performative rather than predictive. Board members, particularly non-executives, leave meetings with a sense of having “covered the bases” but without the confidence to whether care is demonstrably safer or more effective than twelve months ago. Frontline staff, meanwhile, experience “audit fatigue”. The very activity meant to drive improvement becomes a bureaucratic burden that detracts from patient care.
This is not a failure of intent. NHS leaders are deeply committed to quality. The problem is structural: information systems and reporting habits have not kept pace with the complexity of modern care. National audits, Datix incidents, complaints, PREMs, PROMs, staff survey results, mortality indicators (HSMR/SHMI), CQC ratings and local quality improvement projects generate vast data. Yet they arrive fragmented, retrospective and often un-triangulated. Committees receive retrospective compliance narratives rather than forward-looking dashboards that show trajectory and predictive risk.
GGi has long advocated a maturity-matrix approach to quality and clinical governance. Our published matrices (including the site-level matrix for group structures) help organisations assess themselves honestly against clear descriptors of “basic,” “developing,” “mature,” and “exemplar” performance across leadership, data quality, triangulation, escalation, learning, and culture. They move the conversation from “have we done the audit?” to “what has the audit told us about harm reduction, and what are we doing differently as a result?”
Now GGi is collaborating with Tendable to take this work further. Tendable’s digital assurance platform was designed by clinicians for clinicians. Its intuitive mobile app enables frontline teams to complete audits and inspections in a fraction of the time traditionally required, capturing real-time data on safety processes, patient experience, and environmental standards. The accompanying analytics portal triangulates this rich, granular data with other sources (staff feedback, patient surveys, incident reports, etc) to produce dynamic, visual insights that boards and committees can actually use.
Our joint research is examining the information needs of quality committees. We are speaking directly with those who lead them: executive leads (most often Chief Nurses) and non-executive chairs. The goal is simple but ambitious: to identify what data, presented how, and discussed in what way, would enable committees to provide genuine, outcome-focused assurance.
This summer GGi and Tendable will host a series of in-person workshops in London, Birmingham, and Manchester. We are bringing together quality committee chairs, Chief Nurses, Medical Directors and governance leads to co-design enhanced maturity matrices specifically for effective committee assurance. Participants will work through practical exercises that shift discussion from process to outcomes. They will explore hard metrics that answer the fundamental questions:
- Safety: What is the trend in harm events (falls, pressure ulcers, medication errors, healthcare-associated infections)? Has the rate of moderate/severe harm per 1,000 bed days fallen? Is variation across sites or specialties reducing?
- Clinical effectiveness: Are outcome measures (readmission rates, mortality, length of stay, national audit compliance and improvement) improving year on year? Are evidence-based pathways being delivered consistently?
- Patient satisfaction and experience: Are PREMs/PROMs and Friends and Family Test scores rising? Do patient stories and complaints themes show fewer repeats of the same issues?
- Trajectory: Using leading indicators (audit compliance rates, near-miss reporting culture, staff training completion, digital adoption), can we forecast whether next year will be safer still?
The workshops will produce practical tools: updated maturity matrices, example dashboards, and discussion frameworks that steer committee time towards insight and action rather than box-ticking. GGi and Tendable have worked together before and at an April 2022 roundtable (captured in the joint GGi-Tendable paper “How could we get to a place where the chair of the board could say our organisation is safer than it was a year ago?”) we showed strong appetite for this shift. Participants referenced Dr Ernest Codman’s century-old “end result” idea – following every patient to determine whether treatment succeeded or failed and learning systematically from both. Modern technology makes Codman’s vision achievable at scale.
What does good look like? A mature quality committee receives a concise highlight report (no more than 10-15 pages) that opens with a one-page “safety and quality at a glance” dashboard showing year-on-year trends, benchmarked where possible, with RAG-rated trajectory arrows. Papers on individual topics are exception-based. Discussion focuses on three or four deep dives: what the data is telling us, why variation exists, what actions are being taken, and what success will look like in six and twelve months. Non-executives probe for evidence of triangulation and predictive insight. Actions are owned, timed, and followed up at the next meeting. The committee leaves with confidence it can assure the board – and the public – that quality is not just being monitored but actively improved.
The benefits extend far beyond the committee room. Frontline teams see their audit effort translated into visible improvement rather than disappearing into a report. Staff engagement rises when people understand how their data drives change. Regulators see proactive, evidence-based governance rather than retrospective compliance. Most importantly, patients receive demonstrably safer, more effective care.
Clinical governance was never meant to be an administrative exercise. It was meant to embed a culture of continuous learning and accountability. By equipping quality committees with the right information architecture – real-time, triangulated, outcome-focused metrics supported by digital tools – we can finally realise that ambition.
GGi and Tendable are committed to supporting organisations on this journey. We invite quality committee leaders and Chief Nurses to join our summer workshops or contact us directly to discuss how your committee can move from process to genuine assurance. The question “Are we safer this year?” deserves a clear, evidence-based answer. With the right tools and collective effort, we can ensure the answer is not only “yes” today, but even more confidently “yes – and next year will be better still.”
In common with all our publications, this article has been reviewed by a second GGi expert